We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBTA:NYSEIbotta, Inc. analysis

Data as of Sep 1, 2026 - not real-time

Latest price
$37.21
Risk: high
9/10High risk

Summary

Ibotta, Inc. is priced at $37.21 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 15.2%. Relative strength is 55.4 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $30.47 and resistance around $39.91.
Multiples put this in fair territory: 19.8 times earnings against the sector's 35.8. Revenue is growing at 3.3% on a -3.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 142.0%, a beta of 1.28 and a maximum drawdown of 45.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top market events

  • Cash-back rewards platform Ibotta NYSE:IBTA announced in Q2 CY2026, with sales up 3.
  • Cash-back rewards platform Ibotta NYSE:IBTA announced better-than-expected revenue in Q2 CY2026, with sales up 3.
  • Ibotta Inc IBTA beats expectations with 3% revenue growth, driven by a 27% surge in third-party publisher revenue and a...

Market outlook

Short term

< 1 year

Positive

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 28.57
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 19.8 versus sector average of 35.8
  • Trading above the 200-day average of 28.57

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 19.8 versus sector average of 35.8
  • Negative profit margin of -3.2%
  • Negative return on equity of -3.7%

Key metrics

Financial health

Revenue Growth3.30%
Profit Margin-3.21%
P/E Ratio19.8
ROE-3.70%
ROA-1.20%
Debt/Equity10.40
P/B Ratio3.6
Op. Cash Flow$93.2M
Free Cash Flow$50.9M
Industry P/E35.8

Technical analysis

TrendBullish
RSI55.4
Support$30.47
Resistance$39.91
MA 20$37.17
MA 50$33.13
MA 200$28.57
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$37.45
Target Price$36.14
Upside/Downside-2.87%
GradeFair
TypeBlend

Risk assessment

Beta1.28
Volatility142.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.